| Dr Kristen Ann Thomas, MD | |
|
1180 Resurgence Dr, Suite 100, Watkinsville, GA 30677-7210 | |
| (706) 543-5858 | |
| (706) 543-2050 |
| Full Name | Dr Kristen Ann Thomas |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 1180 Resurgence Dr, Watkinsville, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891960696 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 141562 (North Carolina) | Secondary |
| 207N00000X | Dermatology | 67815 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Athens Regional Medical Center | Athens, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Georgia Skin Cancer And Aestheitic Dermatology, Llc | 0244328649 | 20 |
News Archive
According to new research from Harvard and the University of California, San Diego, the short answer on both counts is "yes."
Overhauling the nation's health system has been the president's most significant legislative achievement. As a result, the Court's decision will also reflect on his effectiveness as a leader. Meanwhile, news outlets report on the White House's preparations for the decision.
A combination therapy made up of two neurotrophic factors can reduce the degenerative effects of Parkinson's disease, shows new research.
CytomX Therapeutics, a biotechnology company focused on the development of proteolytically-activated antibodies, today announced it has completed a $30 million Series B financing.
A guide to help battle a potentially fatal disease transferred by a blood-sucking insect called the kissing bug has been published by a task force led by The University of Texas Health Science Center at Houston.
› Verified 4 days ago
| Entity Name | Georgia Skin Cancer & Aestheitic Dermatology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205026168 PECOS PAC ID: 0244328649 Enrollment ID: O20071119000529 |
News Archive
According to new research from Harvard and the University of California, San Diego, the short answer on both counts is "yes."
Overhauling the nation's health system has been the president's most significant legislative achievement. As a result, the Court's decision will also reflect on his effectiveness as a leader. Meanwhile, news outlets report on the White House's preparations for the decision.
A combination therapy made up of two neurotrophic factors can reduce the degenerative effects of Parkinson's disease, shows new research.
CytomX Therapeutics, a biotechnology company focused on the development of proteolytically-activated antibodies, today announced it has completed a $30 million Series B financing.
A guide to help battle a potentially fatal disease transferred by a blood-sucking insect called the kissing bug has been published by a task force led by The University of Texas Health Science Center at Houston.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristen Ann Thomas, MD 1180 Resurgence Dr, Suite100, Watkinsville, GA 30677-7210 Ph: (706) 543-5858 | Dr Kristen Ann Thomas, MD 1180 Resurgence Dr, Suite 100, Watkinsville, GA 30677-7210 Ph: (706) 543-5858 |
News Archive
According to new research from Harvard and the University of California, San Diego, the short answer on both counts is "yes."
Overhauling the nation's health system has been the president's most significant legislative achievement. As a result, the Court's decision will also reflect on his effectiveness as a leader. Meanwhile, news outlets report on the White House's preparations for the decision.
A combination therapy made up of two neurotrophic factors can reduce the degenerative effects of Parkinson's disease, shows new research.
CytomX Therapeutics, a biotechnology company focused on the development of proteolytically-activated antibodies, today announced it has completed a $30 million Series B financing.
A guide to help battle a potentially fatal disease transferred by a blood-sucking insect called the kissing bug has been published by a task force led by The University of Texas Health Science Center at Houston.
› Verified 4 days ago
Ross M Campbell, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1180 Resurgence Dr, Suite 100, Watkinsville, GA 30677 Phone: 706-543-5858 Fax: 706-543-2050 | |
Natalie Marie Meeks, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1180 Resurgence Dr Ste 100, Watkinsville, GA 30677 Phone: 706-543-5858 | |
Cedar Helen Malone, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1180 Resurgence Dr Ste 100, Watkinsville, GA 30677 Phone: 706-543-5858 | |
Adam Swigost, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1220 Langford Dr Ste 103, Watkinsville, GA 30677 Phone: 706-353-8220 Fax: 404-816-7929 | |
Dr. Karen R Maffei, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1050 Thomas Ave, Watkinsville, GA 30677 Phone: 706-769-1550 Fax: 706-769-1514 |